de Bruijn Annefleur M, Smink Marieke, Lohle Paul N M, Huirne Judith A F, Twisk Jos W R, Wong Caroline, Schoonmade Linda, Hehenkamp Wouter J K
Department of Gynecology, VU Medical Center, De Boelelaan 1117, Amsterdam 1081HV, Netherlands.
Department of Gynecology, Elisabeth Tweesteden ziekenhuis, Tilburg, Netherlands.
J Vasc Interv Radiol. 2017 Dec;28(12):1629-1642.e1. doi: 10.1016/j.jvir.2017.07.034. Epub 2017 Oct 9.
The effect of uterine artery embolization (UAE) on symptomatic adenomyosis was evaluated in a systematic review and meta-analysis. Four groups were evaluated: short-term (< 12 months) pure adenomyosis, short-term adenomyosis with fibroids (combined adenomyosis), long-term (> 12 months) pure adenomyosis, and long-term combined adenomyosis. Improvement of symptoms occurred in 83.1% (872/1,049) of patients. Reported symptom reduction was 4.8% greater in the short-term combined group (P = .169) and 11.4% greater in the long-term combined group (P = .003). Uterine volume was reduced in all patients at 3 months. The effects of UAE on symptom improvement and uterine volume reduction in patients with adenomyosis are encouraging.
在一项系统评价和荟萃分析中评估了子宫动脉栓塞术（UAE）对有症状的子宫腺肌病的疗效。评估了四组：短期（<12个月）单纯子宫腺肌病、短期合并子宫肌瘤的子宫腺肌病（合并子宫腺肌病）、长期（>12个月）单纯子宫腺肌病和长期合并子宫腺肌病。83.1%（872/1049）的患者症状得到改善。报告显示，短期合并组症状减轻幅度高4.8%（P = 0.169），长期合并组高11.4%（P = 0.003）。所有患者在3个月时子宫体积均减小。UAE对子宫腺肌病患者症状改善和子宫体积减小的效果令人鼓舞。
